DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

9544	Companies
187983	Keywords
119899	Articles
100421	Press releases

Home
Companies
DBV TECHNOLOGIES

BRIEF

published on 12/16/2025 at 22:10, 14 hours ago

DBV Technologies: Encouraging Results from the VITESSE Study on the Peanut Allergy Patch

DBV Technologies Clinical Results Viaskin Peanut Peanut Allergy SPEED Study
BRIEF

published on 12/16/2025 at 22:10, 14 hours ago

DBV Technologies annonce des résultats positifs de phase 3 pour le patch VIASKIN Peanut.

Essai De Phase 3 Allergie Aux Arachides VIASKIN Cacahuète Soumission De BLA Santé Infantile
BRIEF

published on 12/16/2025 at 22:10, 14 hours ago

DBV Technologies : Résultats Encourageants de l'étude VITESSE sur le Patch Anti-Allergie à l'Arachide

DBV Technologies Résultats Cliniques Viaskin Peanut Allergie Arachide Étude VITESSE
BRIEF

published on 12/16/2025 at 22:10, 14 hours ago

DBV Technologies Reports Positive Phase 3 Results for VIASKIN Peanut Patch

Phase 3 Trial Child Health Viaskin Peanut Peanut Allergy BLA Submission
PRESS RELEASE

published on 12/16/2025 at 22:05, 14 hours 5 minutes ago

DBV Technologies annonce des résultats préliminaires positifs dans l’étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques à l’arachide
DBV Technologies annonce des résultats positifs dans l'étude de phase 3 VITESSE sur VIASKIN Peanut chez les enfants allergiques à l'arachide. Les critères d'évaluation sont atteints, l'innocuité est confirmée

Étude De Phase 3 DBV Technologies Viaskin Peanut Allergie À L'arachide Innocuité
PRESS RELEASE

published on 12/16/2025 at 22:05, 14 hours 5 minutes ago

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies reports positive Phase 3 VITESSE Trial results for VIASKIN Peanut Patch in children aged 4-7 years, meeting primary endpoint with notable treatment response rates and safety profile

Phase 3 DBV Technologies Peanut Allergy Viaskin Peanut Patch VITESSE Trial
BRIEF

published on 11/13/2025 at 17:56, 1 month 3 days ago

Artisan Partners exceeds 5% of the capital in DBV Technologies

Biopharmaceutical Shareholding Crossing Thresholds DBV Technologies Artisan Partners
BRIEF

published on 11/13/2025 at 17:56, 1 month 3 days ago

Artisan Partners dépasse les 5% de capital chez DBV Technologies

Actionnariat Biopharmaceutique Franchissement De Seuils DBV Technologies Artisan Partners
PRESS RELEASE

published on 11/13/2025 at 17:51, 1 month 3 days ago

Franchissement de seuils
Déclaration de franchissement de seuils par Artisan Partners Limited Partnership pour DBV TECHNOLOGIES le 29 octobre 2025

Euronext Paris Franchissement De Seuils Acquisition D'actions DBV Technologies Artisan Partners Limited Partnership
BRIEF

published on 11/12/2025 at 05:55, 1 month 5 days ago

DBV Technologies: Last patient visit in the SPEED trial

Clinical Trial Phase 3 DBV Technologies Peanut Allergy Viaskin® Peanut

Accesswire

Published on 12/17/2025 at 11:37, 33 minutes ago

Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing
Published on 12/17/2025 at 09:05, 3 hours 5 minutes ago

Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies
Published on 12/17/2025 at 08:00, 4 hours 10 minutes ago

Pulsar Helium Awards Security Based Compensation
Published on 12/16/2025 at 23:20, 12 hours 50 minutes ago

Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III
Published on 12/16/2025 at 23:20, 12 hours 50 minutes ago

GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption

View all ACCESSWIRE

EQS Group

Published on 12/17/2025 at 12:04, 6 minutes ago

Edison issues report on VietNam Holding (VNH)
Published on 12/17/2025 at 12:00, 10 minutes ago

AngloGold Ashanti US$9.0m Gold Farm-in Commences
Published on 12/17/2025 at 11:57, 13 minutes ago

Templeton Emerging Markets Investment Trust (TEM)
Published on 12/17/2025 at 11:25, 45 minutes ago

Block listing Six Monthly Return
Published on 12/17/2025 at 11:12, 58 minutes ago

EQS-Adhoc: CEOTRONICS receives third SmG call-off worth approximately € 47 million

Les Echos

Published on 12/16/2025 at 21:45, 14 hours 24 minutes ago

Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 16 hours ago

donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 16 hours ago

Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 17 hours 17 minutes ago

Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 17 hours 17 minutes ago

Nombre total d'actions et droits de vote - novembre 2025

View all LES ECHOS COMFI WIRE